These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6148680)

  • 1. Presence of immunoreactive dynorphin in human cerebrospinal fluid.
    Tozawa F; Suda T; Tachibana S; Tomori N; Demura H; Shizume K
    Life Sci; 1984 Oct; 35(16):1633-7. PubMed ID: 6148680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynorphin A immunoreactivity in human cerebrospinal fluid.
    Nyberg F; Nylander I
    Regul Pept; 1987 Mar; 17(3):159-66. PubMed ID: 2884698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple forms of immunoreactive dynorphin in human pituitary and pheochromocytoma.
    Suda T; Tozawa F; Tachibana S; Demura H; Shizume K; Sasaki A; Mouri T; Miura Y
    Life Sci; 1983 Feb; 32(8):865-70. PubMed ID: 6131371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enkephalin-containing polypeptides in human cerebrospinal fluid.
    Nyberg F; Nylander I; Terenius L
    Brain Res; 1986 Apr; 371(2):278-86. PubMed ID: 2870778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple forms of immunoreactive dynorphin in rat pituitary and brain.
    Suda T; Tozawa F; Tachibana S; Demura H; Shizume K
    Life Sci; 1982 Jul; 31(1):51-7. PubMed ID: 6125864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoreactive peptides related to dynorphin B (= rimorphin) in the rat brain.
    Zhu YX; Höllt V; Loh H
    Peptides; 1983; 4(6):871-4. PubMed ID: 6143300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of immunoreactive dynorphin in human phaeochromocytomas.
    Howlett TA; Besser GM; Rees LH
    J Endocrinol; 1988 Apr; 117(1):123-32. PubMed ID: 2895797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement and chromatographic characterization of prodynorphin-derived peptides in the guinea-pig ileum.
    Steele PA; Turner CA; Murphy R
    Neuropeptides; 1989 Apr; 13(3):207-13. PubMed ID: 2565558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynorphin peptides in human substantia nigra.
    Christensson-Nylander I; Terenius L
    Neuropeptides; 1985 Sep; 6(5):391-6. PubMed ID: 2865698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoreactive dynorphin is regulated by estrogen in the rat anterior pituitary.
    Fullerton MJ; Smith AI; Funder JW
    Neuroendocrinology; 1988 Jan; 47(1):1-6. PubMed ID: 2893308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of immunoreactive dynorphin B and beta-endorphin in human plasma.
    Silberring J; Li YM; Terenius L; Nylander I
    Peptides; 1998; 19(8):1329-37. PubMed ID: 9809646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of electrophoretically separable endorphins in human CSF.
    Nyberg F; Wahlström A; Sjölund B; Terenius L
    Brain Res; 1983 Jan; 259(2):267-74. PubMed ID: 6130823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid dynorphin1-17 and beta-endorphin in late pregnancy and six months after delivery. No influence of acupuncture treatment.
    Lyrenäs S; Nyberg F; Lutsch H; Lindberg B; Terenius L
    Acta Endocrinol (Copenh); 1987 Jun; 115(2):253-8. PubMed ID: 2885996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid dynorphin A[1-8] and beta-endorphin levels in Tourette's syndrome are unaltered.
    van Wattum PJ; Anderson GM; Chappell PB; Goodman WK; Riddle MA; Leckman JF
    Biol Psychiatry; 1999 Jun; 45(11):1527-8. PubMed ID: 10356639
    [No Abstract]   [Full Text] [Related]  

  • 15. Opioid-like activity in the cerebrospinal fluid of pain patients treated by electroacupuncture.
    Ho WK; Wen HL
    Neuropharmacology; 1989 Sep; 28(9):961-6. PubMed ID: 2572998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower CSF level of dynorphin(1-8) immunoreactivity in schizophrenic patients.
    Zhang AZ; Zhou GZ; Xi GF; Gu NF; Xia ZY; Yao JL; Chang JK; Webber R; Potkin S
    Neuropeptides; 1985 Feb; 5(4-6):553-6. PubMed ID: 2860611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of dynorphin A(1-13).
    Brugos B; Hochhaus G
    Pharmazie; 2004 May; 59(5):339-43. PubMed ID: 15212298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynorphin in bovine adrenal medulla. II. Isolation, partial characterization and biological activity of two distinct molecules.
    Denis D; Day R; Lemaire S
    Int J Pept Protein Res; 1982 Jan; 19(1):18-24. PubMed ID: 6126458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a selective processing of proenkephalin B into different opioid peptide forms in particular regions of rat brain and pituitary.
    Seizinger BR; Grimm C; Höllt V; Herz A
    J Neurochem; 1984 Feb; 42(2):447-57. PubMed ID: 6141221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of dynorphin-like immunoreactivity in pheochromocytomas.
    Yoshimasa T; Nakao K; Oki S; Tanaka I; Nakai Y; Imura H
    J Clin Endocrinol Metab; 1981 Jul; 53(1):213-14. PubMed ID: 6113249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.